Regenflex BIO-PLUS Light

Regenflex BIO-PLUS Light is a joint injectable with the same concentration as BIO-PLUS (2.5%), but with a reduced volume specifically for small joints or those not subject to weight-bearing, such as the shoulder. It leverages biorivolumetric technology to ensure viscosupplementation and viscoinduction, improving joint mobility and comfort.

+ 1 syringe
+ 40 mg/1.6 ml
+ HYALURONIC ACID
+ CROSS-LINKED
+ 3 MOLECULAR WEIGHTS

Request info

When to Choose Regenflex BIO-PLUS Light

Indicated for those requiring a gentle or preventative joint intervention. Regenflex BIO-PLUS Light helps reduce inflammation and improve the elasticity of the synovial fluid with a light formula. It is ideal for patients with mild joint pathologies, functional overload, or light sporting activities. Thanks to its balanced composition, it is well-tolerated and perfect for cyclical or maintenance treatments. It supports physiological recovery without weighing down the joints, promoting daily comfort and mobility.

CROSS-LINKED HA + INTERCALATED HA

1+2 MDa cross-linked + 500 kDa intercalated

2.5% concentration HA

Viscosupplementation – high molecular weight
Viscoinduction – low molecular weight
Stimulates synoviocytes to produce endogenous hyaluronic acid
Rapid pain reduction
Protects the cartilage – 500 kda molecular fraction
High dwell time in the articular environment
Gradual release over time ha mw 500 kda
Specific for non weight-bearing joints

CROSS-LINKED AND INTERCALATED HYALURONIC ACID

Biorivolumetria is an innovative concept in the field of injectable medical devices based on hyaluronic acid, which identifies a new category of treatments capable of ensuring both visco-supplementation and visco-induction. BIO-PLUS and BIO-PLUS LIGHT are the two Biorevolumetric products of the Regenflex Project line. Thanks to their patented formula, it is possible to restore the volume of the joint chamber through the introduction of cross-linked hyaluronic acid (visco-supplementation) and a simultaneous receptor stimulating action on synoviocytes and chondrocytes, provided by the linear fraction of intercalated HA (visco-induction), released gradually over time.

SHOULDER – ELBOW – HAND – TEMPOROMANDIBULAR

ACTION ON PAIN
VISCO-SUPPLEMENTATION – HIGH MOLECULAR WEIGHT
VISCO-INDUCTION – LOW MOLECULAR WEIGHT
IMMEDIATE RESULTS
REDUCTION OF INFLAMMATION OVER TIME
PROTECTS AGAINST DAMAGE FROM NSAIDs AND CORTISONE
SLOW-RELEASE ACTION (LINEAR HA)

CROSS-LINKED AND INTERCALATED HYALURONIC ACID
3 MOLECULAR WEIGHTS CROSS-LINKED HA (HA 1+2 MDa) + INTERCALATED LINEAR HA (500 KDa)
VISCO-SUPPLEMENTATIVE AND VISCO-INDUCTIVE FOR JOINTS NOT SUBJECT TO BEARING WEIGHT